Company: SMNR
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0001013762-25-003461
Chunk: 19

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 19
---
 Extension Contribution 
 per Share per Month    |       |
|:-----------------|:----|----------------:|:----|-----------------:|:----|:-----------------------|------:|
| 25%              |     |         187,959 |     |          563,878 |     | $                      | 0.027 |
| 40%              |     |         300,735 |     |          451,102 |     | $                      | 0.033 |
| 50%              |     |         375,919 |     |          375,919 |     | $                      |  0.04 |
| 60%              |     |         451,102 |     |          300,735 |     | $                      |  0.05 |
| 75%              |     |         563,878 |     |          187,959 |     | $                      |  0.08 |
| 85%              |     |         639,061 |     |          112,776 |     | $                      |  0.13 |

| No Extension Payment will occur if the Extension Amendment Proposal is not approved. The Extension Payment does not bear interest and will be repayable by the Company to the Sponsor (or its affiliates or permitted designees or a third party, as applicable) upon consummation of an initial business combination. If the Company decides to not utilize the Extension Amendment, then the Company will liquidate and dissolve promptly in accordance with the amended and restated memorandum and articles of association of the Company, and the Sponsor’s obligation to make additional contributions will terminate. |
| If we determine prior to the time of the extraordinary general meeting that it is not appropriate to submit the Extension Amendment Proposal to the extraordinary general meeting, then the extraordinary general meeting may be adjourned indefinitely, in which case we will liquidate and dissolve in accordance with the amended and restated memorandum and articles of association of the Company if we do not complete an initial business combination by the Termination Date.                                                                                                                                       |

7

| What happens to the Company’s warrants if the Extension Amendment Proposal is not approved?             |     | If the Extension Amendment Proposal is not approved and we have not consummated an initial business combination by the Termination Date, we will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem